Search
Search Results
##search.searchResults.foundPlural##
-
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3249PDF: 2244HTML: 23307Untitled: 191Untitled: 202Untitled: 220 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2032PDF: 1629HTML: 351 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2767PDF: 990HTML: 5506 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12296PDF: 1653HTML: 4151Cover letter: 188Figure 1: 190 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3149PDF: 1396HTML: 5836Fig1-Ag-Pil: 207Ag-Pil Fig.2: 215 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
8954PDF: 6005HTML: 87919Fig.1b: 172Fig.1c: 171Fig.2a: 164Fig.2b: 163Fig.4: 175Fig.2c: 170Fig.3: 169Tab.1: 215Tab.2: 194Tab.3: 180Tab.4: 207Fig1a: 165 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
3934PDF: 1279HTML: 2249 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1650PDF: 732HTML: 474 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1567PDF: 791HTML: 149 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4039PDF: 1554HTML: 885 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1335HTML: 378PDF: 803 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4743PDF: 1765HTML: 2115 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4253PDF: 1717HTML: 1098 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1470PDF: 912HTML: 214 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1927PDF: 697HTML: 672Table1: patient's characteristics: 143Table 2: profile of each patient: 168 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1151PDF: 1037HTML: 181 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1595PDF: 1158HTML: 188 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3483PDF: 2372HTML: 1433 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1802HTML: 1401PDF: 1053 -
Pseudo-differentiation syndrome
1316PDF: 643HTML: 10833Figure 1: peripheral blood showing myeloblasts with auer rods: 108Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 96Figure 3: CXR showing pulmonary infiltartes with consolidation: 128Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 100Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 110 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1344PDF: 1280HTML: 84 -
A STUDY ON THE EXPRESSION OF BCR-ABL TRANSCRIPT IN MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) CASES USING THE REVERSE TRANSCRIPTASE POLYMERASE REACTION ASSAY (RT-PCR) AND ITS CORRELATION WITH HEMATOLOGICAL REMISSION STATUS POST INITIAL INDUCTION THERAPY
1324PDF: 801HTML: 5024INSTITUTE PUBLICATION COMMITTEE APPROVAL: 151 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
916PDF: 562HTML: 325 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3543PDF: 861HTML: 6701 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1283PDF: 789HTML: 120 -
The significance of purity: Leukaemias involving the erythroid lineage Erythroid lineage leukemia
782PDF: 408HTML: 276 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2122PDF: 1554HTML: 251 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1475PDF: 514HTML: 256 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
711PDF: 457HTML: 6253 -
-
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4363PDF: 1593HTML: 3508Tables and Images: 203 -
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
982PDF: 360HTML: 82 -
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1
1088PDF: 492HTML: 171







